Arrhythmia Disorders News

Three studies published recently indicate that women who undergo heart surgery are less likely to receive guideline-directed care and more likely to have poor outcomes compared with men.

In the largest study to date of pulsed field ablation for patients with atrial fibrillation, the technology was associated with low rates of major complications, especially esophageal damage.

Pre-participation screening, particularly whether an ECG should be included as part of a pre-participation exam for young athletes, is one of the most widely debated topics in sports cardiology.

People with narcolepsy were more likely than propensity score-matched people without narcolepsy to develop heart disease, regardless of sleep apnea status, according to a retrospective cohort study.

AliveCor announced the FDA clearance and launch of its AI system designed to detect 35 cardiac conditions using a reduced leadset, in addition to its single-cable, AI-powered handheld ECG System.

Elutia Inc. announced the FDA clearance of its antibiotic-eluting bio-envelope designed to prevent postoperative infection, migration and erosion for implanted devices such as pacemakers and defibrillators.

Fewer ICU/ED patients experienced hypoxemia during intubation with receipt of preoxygenation with noninvasive ventilation vs. an oxygen mask, according to research published in the New England Journal of Medicine.

Return-to-play considerations and CVD risks of people who perform under life-threatening conditions were among the key sports cardiology topics at the American College of Cardiology Scientific Session in April in Atlanta.

Due to demographic changes and a rise in risk factors, the prevalence and economic burden of heart disease and stroke in the United States are expected to increase dramatically by 2050, according to the American Heart Association.

A single burst of antitachycardia pacing before an implantable cardioverter defibrillator shock lowered risk for all-cause shock compared with a standard shock protocol, according to the results of the APPRAISE ATP trial.